glp-1 conference Contact Us GLP-1s: The world's first longevity
Description
Sources: Harvard Health Publishing
Rossing, M.L
Probably the improvement in glucose homeostasis contributed to a higher survival rate in animals treated with the QV formulation than untreated diabetic rats and diabetic rats treated with a daily dose of insulin, suggesting that the treatment with formulation may be associated with a low risk of the hypoglycemia that sometimes results from insulin administration 15
Decreases insulin requirement
This side effect seems to be unique to GLP-1s, connected mostly to how they work in the brain
The potential for renoprotection with incretin-based drugs
